Welcome to LookChem.com Sign In|Join Free

CAS

  • or
D-Plenylglycinol is a chiral arylalkylamine that exists as a white to light yellow crystalline powder. It is known for its unique chemical properties and potential applications in various industries due to its organocatalytic capabilities.

56613-80-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 56613-80-0 Structure
  • Basic information

    1. Product Name: D-Plenylglycinol
    2. Synonyms: D-PHENYLGLYCINOL;d-plenylglycinol;D-PHG-OL;D-(-)2-AMINO-2-PHENYLETHANOL;D(-)-ALPHA-PHENYLGLYCINOL;D-(-)-A-PHENYLGLYCINOL;H-D-PHG-OL;BENZENEETHANOL, B-AMINO-, (BR)-
    3. CAS NO:56613-80-0
    4. Molecular Formula: C8H11NO
    5. Molecular Weight: 137.18
    6. EINECS: 260-287-5
    7. Product Categories: Pharmaceutical Intermediates;Alcohols and Derivatives;Amino Alcohols;chiral;Chiral Reagent;Phenylglycine [Phg];Amino Alcohols (Chiral);Asymmetric Synthesis;Chiral Building Blocks;Synthetic Organic Chemistry;Amino alcohols;Benzene derivatives;Amines;Aromatics;Catalyst;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals
    8. Mol File: 56613-80-0.mol
    9. Article Data: 119
  • Chemical Properties

    1. Melting Point: 76-79 °C
    2. Boiling Point: 252.03°C (rough estimate)
    3. Flash Point: 125.3 °C
    4. Appearance: White to yellow/Crystalline Powder
    5. Density: 1.0630 (rough estimate)
    6. Vapor Pressure: 0.00601mmHg at 25°C
    7. Refractive Index: -29.5 ° (C=1, EtOH)
    8. Storage Temp.: Store at 0-5°C
    9. Solubility: Aqueous Acid (Slightly, Sonicated), Chloroform (Sparingly, Heated), Methanol (Slightly)
    10. PKA: 12.51±0.10(Predicted)
    11. Water Solubility: Slightly soluble in water.
    12. Sensitive: Air Sensitive
    13. BRN: 2935848
    14. CAS DataBase Reference: D-Plenylglycinol(CAS DataBase Reference)
    15. NIST Chemistry Reference: D-Plenylglycinol(56613-80-0)
    16. EPA Substance Registry System: D-Plenylglycinol(56613-80-0)
  • Safety Data

    1. Hazard Codes: C,T
    2. Statements: 34-36/37/38-23/24/25
    3. Safety Statements: 22-24/25-45-36/37/39-26
    4. WGK Germany: 3
    5. RTECS:
    6. F: 2-10
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 56613-80-0(Hazardous Substances Data)

56613-80-0 Usage

Uses

Used in Chemical Synthesis:
D-Plenylglycinol is used as a chiral arylalkylamine in the synthesis of novel fluorescent chemosensors for amino acids. Its organocatalytic properties enable the development of new compounds with enhanced chiral recognition, which is crucial for various applications in the chemical and pharmaceutical industries.
Used in Analytical Chemistry:
In the field of analytical chemistry, D-Plenylglycinol is utilized as an organocatalyst for the synthesis and chiral recognition properties of novel fluorescent chemosensors. These chemosensors are essential for detecting and analyzing amino acids, which are the building blocks of proteins and play a vital role in various biological processes.
Used in Pharmaceutical Industry:
The pharmaceutical industry can benefit from D-Plenylglycinol's organocatalytic properties in the development of new drugs and drug delivery systems. Its ability to act as a chiral arylalkylamine in the synthesis of novel compounds can lead to the creation of more effective and targeted medications.
Used in Research and Development:
D-Plenylglycinol's unique properties make it a valuable tool in research and development, particularly in the fields of chemistry and biology. Its use as an organocatalyst can facilitate the discovery of new compounds and materials with potential applications in various industries.

Check Digit Verification of cas no

The CAS Registry Mumber 56613-80-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,6,1 and 3 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 56613-80:
(7*5)+(6*6)+(5*6)+(4*1)+(3*3)+(2*8)+(1*0)=130
130 % 10 = 0
So 56613-80-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H11NO/c9-8(6-10)7-4-2-1-3-5-7/h1-5,8,10H,6,9H2/p+1/t8-/m0/s1

56613-80-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (P1201)  (R)-(-)-2-Phenylglycinol  >98.0%(GC)(T)

  • 56613-80-0

  • 5g

  • 690.00CNY

  • Detail
  • TCI America

  • (P1201)  (R)-(-)-2-Phenylglycinol  >98.0%(GC)(T)

  • 56613-80-0

  • 25g

  • 2,360.00CNY

  • Detail
  • Alfa Aesar

  • (A19030)  (R)-(-)-2-Phenylglycinol, 98%   

  • 56613-80-0

  • 1g

  • 255.0CNY

  • Detail
  • Alfa Aesar

  • (A19030)  (R)-(-)-2-Phenylglycinol, 98%   

  • 56613-80-0

  • 5g

  • 836.0CNY

  • Detail
  • Alfa Aesar

  • (A19030)  (R)-(-)-2-Phenylglycinol, 98%   

  • 56613-80-0

  • 25g

  • 3004.0CNY

  • Detail
  • Aldrich

  • (190357)  (R)-(−)-2-Phenylglycinol  98%

  • 56613-80-0

  • 190357-5G

  • 782.38CNY

  • Detail
  • Aldrich

  • (190357)  (R)-(−)-2-Phenylglycinol  98%

  • 56613-80-0

  • 190357-25G

  • 3,023.28CNY

  • Detail

56613-80-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (R)-(-)-2-Phenylglycinol

1.2 Other means of identification

Product number -
Other names D-Plenylglycinol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56613-80-0 SDS

56613-80-0Synthetic route

N-[(1R)-2-hydroxy-1-phenylethyl]-N-[(1S)-1-(tributylstannyl)but-3-en-1-yl]benzenesulfonamide
1175712-18-1, 1175712-19-2

N-[(1R)-2-hydroxy-1-phenylethyl]-N-[(1S)-1-(tributylstannyl)but-3-en-1-yl]benzenesulfonamide

A

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

B

bis(tri-n-butyltin)
813-19-4

bis(tri-n-butyltin)

Conditions
ConditionsYield
With tetra(n-butyl)ammonium hydrogensulfate In acetonitrile Inert atmosphere; Electrolysis;A 96%
B n/a
(R)-phenylglycine
875-74-1

(R)-phenylglycine

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
Stage #1: (R)-phenylglycine With sodium tetrahydroborate; iodine In tetrahydrofuran at 64℃; for 18h;
Stage #2: With methanol In tetrahydrofuran at 20℃;
94%
With lithium borohydride; chloro-trimethyl-silane In tetrahydrofuran at 0 - 20℃; for 49h;93%
With lithium aluminium tetrahydride In tetrahydrofuran for 20h; Heating;92%
(R)-2-azido-2-phenylethan-1-ol
126923-26-0

(R)-2-azido-2-phenylethan-1-ol

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
With water; triphenylphosphine In tetrahydrofuran at 70℃; Staudinger Azide Reduction;92%
With hydrogen; palladium on activated charcoal
N-((1R)-2-hydroxy-1-phenylethyl)acetamide
78761-26-9

N-((1R)-2-hydroxy-1-phenylethyl)acetamide

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
Stage #1: N-[(1R)-2-hydroxy-1-phenylethyl]acetamide With Schwartz's reagent In tetrahydrofuran at 20℃; for 0.0666667h; Inert atmosphere;
Stage #2: With water In tetrahydrofuran Inert atmosphere;
89%
(1'R,3R)-3-Hydroxy-N-(2-hydroxy-1-phenylethyl)-4-methylpentanamid
87319-84-4

(1'R,3R)-3-Hydroxy-N-(2-hydroxy-1-phenylethyl)-4-methylpentanamid

A

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

B

(R)-3-hydroxy-4-methylpentanoic acid
77981-87-4

(R)-3-hydroxy-4-methylpentanoic acid

C

(3S)-3-hydroxy-4-methylpentanoic acid
63674-22-6

(3S)-3-hydroxy-4-methylpentanoic acid

Conditions
ConditionsYield
With potassium hydroxide In methanol; water for 15h; Heating;A n/a
B 88%
C n/a
(1'R,3S)-3-Hydroxy-N-(2-hydroxy-1-phenylethyl)-hexanamid
87319-85-5

(1'R,3S)-3-Hydroxy-N-(2-hydroxy-1-phenylethyl)-hexanamid

A

(-)-(3R)-3-hydroxyhexanoic acid
77877-35-1

(-)-(3R)-3-hydroxyhexanoic acid

B

(+)-(3S)-3-hydroxyhexanoic acid
66997-60-2

(+)-(3S)-3-hydroxyhexanoic acid

C

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
With potassium hydroxide In methanol; water for 15h; Heating;A n/a
B 86%
C n/a
(R)-amino-phenyl-acetic acid ethyl ester
39251-40-6

(R)-amino-phenyl-acetic acid ethyl ester

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
With lithium aluminium tetrahydride
With methanol; nickel at 40℃; under 110326 Torr; Hydrogenation;
(R)-N-benzyl-2-phenylglycinol
14231-57-3

(R)-N-benzyl-2-phenylglycinol

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
With hydrogen; palladium dichloride In methanol for 1h;
(1R,2R,5R)-3-[(E)-(R)-2-Hydroxy-1-phenyl-ethylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol
134356-93-7

(1R,2R,5R)-3-[(E)-(R)-2-Hydroxy-1-phenyl-ethylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
With hydroxylamine acetate In ethanol for 20h; Ambient temperature; Yield given;
(4S)-4-phenyl[1,3]dioxolan-2-one
4427-92-3, 90971-11-2, 129097-94-5, 90970-80-2

(4S)-4-phenyl[1,3]dioxolan-2-one

A

(S)-2-Amino-1-phenyl-1-ethanol
56613-81-1

(S)-2-Amino-1-phenyl-1-ethanol

B

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
With hydrogenchloride; sodium azide; water; hydrogen; palladium on activated charcoal 1.) DMF, 70 deg C, 48 h; 2.) ethanol, r.t.; Yield given. Multistep reaction;
(S)-2-phenylglycine
2935-35-5

(S)-2-phenylglycine

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
With lithium borohydride; sulfuric acid In tetrahydrofuran for 24h; Ambient temperature;
tert-butyl 2-hydroxy-1-phenylethylcarbamate
102089-74-7, 117049-14-6, 138457-46-2, 67341-01-9

tert-butyl 2-hydroxy-1-phenylethylcarbamate

A

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

B

(2S)-2-phenylglycinol
20989-17-7

(2S)-2-phenylglycinol

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane for 1h; Ambient temperature; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
methanol
67-56-1

methanol

(R)-amino-phenyl-acetic acid ethyl ester
39251-40-6

(R)-amino-phenyl-acetic acid ethyl ester

Raney nickel

Raney nickel

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
at 40℃; under 110326 Torr; Hydrogenation;
N-<(R)-2-hydroxy-1-phenyl-ethyl>-benzamide

N-<(R)-2-hydroxy-1-phenyl-ethyl>-benzamide

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
With ethanol; palladium Hydrogenation;
(R)-N-(tert-butoxycarbonyl)phenylglycinol
67341-01-9, 117049-14-6, 138457-46-2, 102089-74-7

(R)-N-(tert-butoxycarbonyl)phenylglycinol

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
With hydrogenchloride In tetrahydrofuran for 48h; BOC-deprotection;
(RS,1R)-2-methylpropane-2-sulfinic acid [1-((tert-butyldimethylsilanyloxy)methyl)-1-phenylethyl]amide
342651-76-7

(RS,1R)-2-methylpropane-2-sulfinic acid [1-((tert-butyldimethylsilanyloxy)methyl)-1-phenylethyl]amide

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane; methanol at 20℃; for 0.5h;
ethyl 2-(hydroxyimino)-2-phenylacetate
131934-09-3, 135765-81-0, 712-41-4

ethyl 2-(hydroxyimino)-2-phenylacetate

A

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

B

O=CH(CH2)5NHCOO-Wang-polystyrene

O=CH(CH2)5NHCOO-Wang-polystyrene

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: 85 percent / NaBH4; I2 / tetrahydrofuran / 4 h / Heating
2.1: dibenzoyl-L-tartaric acid / acetone / 6 h / 25 °C
2.2: aq. KOH / CH2Cl2
View Scheme
(S,E)-N-benzylidene-4-methylbenzenesulfinamide
350479-90-2

(S,E)-N-benzylidene-4-methylbenzenesulfinamide

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 98 percent / i-Pr2NH; BuLi / tetrahydrofuran; hexane / 0.25 h / -78 °C
2: 95 percent / TFA / methanol / 15 h / 20 °C
3: 91 percent / Et3N / acetonitrile / 15 h / 20 °C
4: sym-collidine; TFAA / acetonitrile / 0.25 h / 0 °C
5: 1N HCl / tetrahydrofuran / 48 h
View Scheme
Multi-step reaction with 5 steps
1: i-Pr2NH; BuLi / tetrahydrofuran; hexane / 0 °C
2: 95 percent / TFA / methanol / 15 h / 20 °C
3: 91 percent / Et3N / acetonitrile / 15 h / 20 °C
4: sym-collidine; TFAA / acetonitrile / 0.25 h / 0 °C
5: 1N HCl / tetrahydrofuran / 48 h
View Scheme
(1R,RS)-1-phenyl-2-p-tolylsulfinylethylamine
280128-39-4

(1R,RS)-1-phenyl-2-p-tolylsulfinylethylamine

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 91 percent / Et3N / acetonitrile / 15 h / 20 °C
2: sym-collidine; TFAA / acetonitrile / 0.25 h / 0 °C
3: 1N HCl / tetrahydrofuran / 48 h
View Scheme
tert-butyl N-[(1R,RS)-1-phenyl-2-p-tolylsulfinylethyl]carbamate
280128-43-0

tert-butyl N-[(1R,RS)-1-phenyl-2-p-tolylsulfinylethyl]carbamate

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sym-collidine; TFAA / acetonitrile / 0.25 h / 0 °C
2: 1N HCl / tetrahydrofuran / 48 h
View Scheme
furfural
98-01-1

furfural

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

(R)-2-{[1-Furan-2-yl-meth-(E)-ylidene]-amino}-2-phenyl-ethanol
139437-47-1

(R)-2-{[1-Furan-2-yl-meth-(E)-ylidene]-amino}-2-phenyl-ethanol

Conditions
ConditionsYield
With magnesium sulfate In dichloromethane at 20℃; for 12h;100%
In benzene Heating;88%
In benzene Heating;85%
With magnesium sulfate In dichloromethane
In toluene Condensation; Heating;
3-thiophene carboxaldehyde
498-62-4

3-thiophene carboxaldehyde

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

(R)-2-Phenyl-2-{[1-thiophen-3-yl-meth-(E)-ylidene]-amino}-ethanol
139437-49-3

(R)-2-Phenyl-2-{[1-thiophen-3-yl-meth-(E)-ylidene]-amino}-ethanol

Conditions
ConditionsYield
With magnesium sulfate In dichloromethane at 20℃; for 12h;100%
In benzene Heating;92%
methoxymethyl phenyl ketone
4079-52-1

methoxymethyl phenyl ketone

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

(R)-2,4-diphenyl-2-(methoxymethyl)-1,3-oxazolidine
103621-11-0, 103621-12-1

(R)-2,4-diphenyl-2-(methoxymethyl)-1,3-oxazolidine

Conditions
ConditionsYield
With toluene-4-sulfonic acid In benzene for 72h; Heating;100%
4-oxo-6-phenylhexanoic acid
13122-67-3

4-oxo-6-phenylhexanoic acid

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

(3R,7aS)-3-phenyl-7a-(2-phenylethyl)-2,3,7,7a-tetrahydropyrrolo[2,1-b]oxazol-5-one
675589-40-9

(3R,7aS)-3-phenyl-7a-(2-phenylethyl)-2,3,7,7a-tetrahydropyrrolo[2,1-b]oxazol-5-one

Conditions
ConditionsYield
In toluene for 36h; Reflux;100%
In toluene at 130℃; for 36h;99%
Heating;77%
In toluene Heating;76.5%
(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

benzaldehyde
100-52-7

benzaldehyde

β-[(phenylmethylene)amino]-[R-(E)-]-benzeneethanol
153924-63-1

β-[(phenylmethylene)amino]-[R-(E)-]-benzeneethanol

Conditions
ConditionsYield
With magnesium sulfate In dichloromethane at 20℃; for 12h;100%
In benzene for 4h; Heating;94%
In benzene for 3h; Heating;94%
cinnamoyl chloride
35086-79-4, 95602-71-4

cinnamoyl chloride

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

(E)-3-(4-Chloro-phenyl)-N-((R)-2-hydroxy-1-phenyl-ethyl)-acrylamide
185761-28-8

(E)-3-(4-Chloro-phenyl)-N-((R)-2-hydroxy-1-phenyl-ethyl)-acrylamide

Conditions
ConditionsYield
With sodium carbonate In dichloromethane Ambient temperature;100%
3-pyridinecarboxaldehyde
500-22-1

3-pyridinecarboxaldehyde

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

C14H14N2O

C14H14N2O

Conditions
ConditionsYield
With magnesium sulfate In dichloromethane at 20℃; for 12h;100%
pyridine-4-carbaldehyde
872-85-5

pyridine-4-carbaldehyde

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

C14H14N2O

C14H14N2O

Conditions
ConditionsYield
With magnesium sulfate In dichloromethane at 20℃; for 12h;100%
(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

(1,1-difluoroprop-1-en-2-yloxy)trimethylsilane
1018435-02-3

(1,1-difluoroprop-1-en-2-yloxy)trimethylsilane

(E)-2,2-difluoro-1-methylethylidene((1R)-2-trimethylsilyloxy-1-phenylethyl)amine
1018434-46-2

(E)-2,2-difluoro-1-methylethylidene((1R)-2-trimethylsilyloxy-1-phenylethyl)amine

Conditions
ConditionsYield
In diethyl ether100%
(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

acrylic acid methyl ester
292638-85-8

acrylic acid methyl ester

C12H17NO3
1174637-67-2

C12H17NO3

Conditions
ConditionsYield
In methanol Michael addition;100%
In methanol for 3h; Reflux;
C44H48N4O4(2+)*2Cl(1-)

C44H48N4O4(2+)*2Cl(1-)

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

C60H66N6O4(2+)*2Cl(1-)

C60H66N6O4(2+)*2Cl(1-)

Conditions
ConditionsYield
In dichloromethane at 20℃; for 20h; Inert atmosphere;100%
(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

2-nitrophenyl isocyanate
3320-86-3

2-nitrophenyl isocyanate

N-[(1R)-2-Hydroxy-1-phenylethyl]-N'-(2-nitrophenyl)urea

N-[(1R)-2-Hydroxy-1-phenylethyl]-N'-(2-nitrophenyl)urea

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 1h;100%
(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

acrolein
107-02-8

acrolein

(3R,9R)-3,9-diphenyldi[1,3]oxazolidino[3,2-a:3',2'-e][1,5]diazacyclooctane

(3R,9R)-3,9-diphenyldi[1,3]oxazolidino[3,2-a:3',2'-e][1,5]diazacyclooctane

Conditions
ConditionsYield
In chloroform at 20℃;100%
In chloroform at 20℃; for 0.0833333h;
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

(R)-N-(tert-butoxycarbonyl)phenylglycinol
67341-01-9, 117049-14-6, 138457-46-2, 102089-74-7

(R)-N-(tert-butoxycarbonyl)phenylglycinol

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 20℃;99%
With triethylamine In tetrahydrofuran at 0℃; for 3h;99%
With triethylamine In tetrahydrofuran at 0℃; for 3h; Inert atmosphere;99%
(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

chloroacetyl chloride
79-04-9

chloroacetyl chloride

(R)-2-chloro-N-(2-hydroxy-1-phenylethyl)acetamide
94193-77-8

(R)-2-chloro-N-(2-hydroxy-1-phenylethyl)acetamide

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 25℃;99%
With sodium hydroxide In dichloromethane; water at 0℃; for 1.5h;76%
With triethylamine In tetrahydrofuran; ethanol for 10h;64%
With triethylamine In tetrahydrofuran at 0℃; for 0.166667h; Inert atmosphere;3.54 g
3,4,5,6-Tetrahydrophthalic anhydride
2426-02-0

3,4,5,6-Tetrahydrophthalic anhydride

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

2-[(1R)-2-hydroxy-1-phenylethyl]-4,5,6,7-tetrahydro-1H-isoindole-1,3(2H)-dione
938082-20-3

2-[(1R)-2-hydroxy-1-phenylethyl]-4,5,6,7-tetrahydro-1H-isoindole-1,3(2H)-dione

Conditions
ConditionsYield
In toluene for 3h; Heating;99%
In toluene Heating;97%
(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Triethyl orthopropionate
115-80-0

Triethyl orthopropionate

(4R)-2-ethyl-4-phenyl-2-oxazoline
205178-47-8

(4R)-2-ethyl-4-phenyl-2-oxazoline

Conditions
ConditionsYield
With acetic acid In 1,2-dichloro-ethane for 2h; Cyclization; Heating;99%
n-hexyl chloroformate
6092-54-2

n-hexyl chloroformate

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

hexyl (1R)-2-hydroxy-1-phenylethylcarbamate
532986-19-9

hexyl (1R)-2-hydroxy-1-phenylethylcarbamate

Conditions
ConditionsYield
With sodium hydrogencarbonate In 1,4-dioxane at 0℃; for 2h;99%
(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

Heptanoic acid chloride
2528-61-2

Heptanoic acid chloride

N-[(1R)-2-hydroxy-1-phenylethyl]heptanamide
532986-14-4

N-[(1R)-2-hydroxy-1-phenylethyl]heptanamide

Conditions
ConditionsYield
With sodium hydrogencarbonate In 1,4-dioxane at 0℃; for 2h;99%
2-chloro-4-methylquinoline
634-47-9

2-chloro-4-methylquinoline

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

(R)-N-(4-methyl-2-quinolyl)-phenylglycinol

(R)-N-(4-methyl-2-quinolyl)-phenylglycinol

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In isopropyl alcohol at 130℃; for 46h;99%
4-(Diethylamino)salicylaldehyde
17754-90-4

4-(Diethylamino)salicylaldehyde

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

(E)-5-diethylamino-2-[(2-hydroxy-(1R)-phenylethylimino)methyl]phenol

(E)-5-diethylamino-2-[(2-hydroxy-(1R)-phenylethylimino)methyl]phenol

Conditions
ConditionsYield
In toluene for 8h; Heating;99%
In ethanol for 1h; Heating;95%

56613-80-0Relevant articles and documents

Reactive extraction of enantiomers of 1,2-amino alcohols via stereoselective thermodynamic and kinetic processes

Tang, Lijun,Choi, Sujung,Nandhakumar, Raju,Park, Flyunjung,Chung, Hyein,Chin, Jik,Kwan, Mook Kim

, p. 5996 - 5999 (2008)

(Chemical Equation Presented) (R)-Amino alcohol with an enantiomeric excess of >95% was resolved by reactive extraction processes from 2 equiv of racemic alcohol using a chiral receptor 2 as an enantioselective extractant. One resolution cycle is composed of three extractions: a stereoselective reversible imine formation, a stereoselective irreversible imine hydrolysis, and the recovery of 2 and enantiomeric amino alcohols.

Construction and activity evaluation of novel dual-target (SE/CYP51) anti-fungal agents containing amide naphthyl structure

An, Yunfei,Fan, Haiyan,Han, Jun,Liu, Wenxia,Liu, Yating,Sun, Bin,Sun, Zhuang

, (2021/11/16)

With the increase of fungal infection and drug resistance, it is becoming an urgent task to discover the highly effective antifungal drugs. In the study, we selected the key ergosterol bio-synthetic enzymes (Squalene epoxidase, SE; 14 α-demethylase, CYP51) as dual-target receptors to guide the construction of novel antifungal compounds, which could achieve the purpose of improving drug efficacy and reducing drug-resistance. Three different series of amide naphthyl compounds were generated through the method of skeleton growth, and their corresponding target products were synthesized. Most of compounds displayed the obvious biological activity against different Candida spp. and Aspergillus fumigatus. Among of them, target compounds 14a-2 and 20b-2 not only possessed the excellent broad-spectrum anti-fungal activity (MIC50, 0.125–2 μg/mL), but also maintained the anti-drug-resistant fungal activity (MIC50, 1–4 μg/mL). Preliminary mechanism study revealed the compounds (14a-2, 20b-2) could block the bio-synthetic pathway of ergosterol by inhibiting the dual-target (SE/CYP51) activity, and this finally caused the cleavage and death of fungal cells. In addition, we also discovered that compounds 14a-2 and 20b-2 with low toxic and side effects could exert the excellent therapeutic effect in mice model of fungal infection, which was worthy for further in-depth study.

Highly Stable Zr(IV)-Based Metal-Organic Frameworks for Chiral Separation in Reversed-Phase Liquid Chromatography

Jiang, Hong,Yang, Kuiwei,Zhao, Xiangxiang,Zhang, Wenqiang,Liu, Yan,Jiang, Jianwen,Cui, Yong

supporting information, p. 390 - 398 (2021/01/13)

Separation of racemic mixtures is of great importance and interest in chemistry and pharmacology. Porous materials including metal-organic frameworks (MOFs) have been widely explored as chiral stationary phases (CSPs) in chiral resolution. However, it remains a challenge to develop new CSPs for reversed-phase high-performance liquid chromatography (RP-HPLC), which is the most popular chromatographic mode and accounts for over 90% of all separations. Here we demonstrated for the first time that highly stable Zr-based MOFs can be efficient CSPs for RP-HPLC. By elaborately designing and synthesizing three tetracarboxylate ligands of enantiopure 1,1′-biphenyl-20-crown-6, we prepared three chiral porous Zr(IV)-MOFs with the framework formula [Zr6O4(OH)8(H2O)4(L)2]. They share the same flu topological structure but channels of different sizes and display excellent tolerance to water, acid, and base. Chiral crown ether moieties are periodically aligned within the framework channels, allowing for stereoselective recognition of guest molecules via supramolecular interactions. Under acidic aqueous eluent conditions, the Zr-MOF-packed HPLC columns provide high resolution, selectivity, and durability for the separation of a variety of model racemates, including unprotected and protected amino acids and N-containing drugs, which are comparable to or even superior to several commercial chiral columns for HPLC separation. DFT calculations suggest that the Zr-MOF provides a confined microenvironment for chiral crown ethers that dictates the separation selectivity.

Bioproduction of Enantiopure (R)- and (S)-2-Phenylglycinols from Styrenes and Renewable Feedstocks

Sekar, Balaji Sundara,Mao, Jiwei,Lukito, Benedict Ryan,Wang, Zilong,Li, Zhi

, p. 1892 - 1903 (2020/12/22)

Enantiopure (R)- and (S)-2-phenylglycinols are important chiral building blocks for pharmaceutical manufacturing. Several chemical and enzymatic methods for their synthesis were reported, either involving multi-step synthesis or starting from a relatively complex chemical. Here, we developed one-pot simple syntheses of enantiopure (R)- and (S)-2-phenylglycinols from cheap starting materials and renewable feedstocks. Enzyme cascades consisting of epoxidation-hydrolysis-oxidation-transamination were developed to convert styrene 2 a to (R)- and (S)-2-phenylglycinol 1 a, with butanediol dehydrogenase for alcohol oxidation as well as BmTA and NfTA for (R)- and (S)-enantioselective transamination, respectively. The engineered E. coli strains expressing the cascades produced 1015 mg/L (R)-1 a in >99% ee and 315 mg/L (S)-1 a in 91% ee, respectively, from styrene 2 a. The same cascade also converted substituted styrenes 2 b–k and indene 2 l into substituted (R)-phenylglycinols 1 b–k and (1R, 2R)-1-amino-2-indanol 1 l in 95–>99% ee. To transform bio-based L-phenylalanine 6 to (R)-1 a and (S)-1 a, (R)- and (S)-enantioselective enzyme cascades for deamination-decarboxylation-epoxidation-hydrolysis-oxidation-transamination were developed. The engineered E. coli strains produced (R)-1 a and (S)-1 a in high ee at 576 mg/L and 356 mg/L, respectively, from L-phenylalanine 6, as the first synthesis of these compounds from a bio-based chemical. Finally, L-phenylalanine biosynthesis pathway was combined with (R)- or (S)-enantioselective cascade in one strain or coupled strains, to achieve the first synthesis of (R)-1 a and (S)-1 a from a renewable feedstock. The coupled strain approach enhanced the production, affording 274 and 384 mg/L (R)-1 a and 274 and 301 mg/L (S)-1 a, from glucose and glycerol, respectively. The developed methods could be potentially useful to produce these high-value chemicals from cheap starting materials and renewable feedstocks in a green and sustainable manner. (Figure presented.).

Site-Specific C(sp3)–H Aminations of Imidates and Amidines Enabled by Covalently Tethered Distonic Radical Anions

Fang, Yuanding,Fu, Kang,Shi, Lei,Zhao, Rong,Zhou, Jia

supporting information, p. 20682 - 20690 (2020/09/07)

The utilization of N-centered radicals to synthesize nitrogen-containing compounds has attracted considerable attention recently, due to their powerful reactivities and the concomitant construction of C?N bonds. However, the generation and control of N-centered radicals remain particularly challenging. We report a tethering strategy using SOMO-HOMO-converted distonic radical anions for the site-specific aminations of imidates and amidines with aid of the non-covalent interaction. This reaction features a remarkably broad substrate scope and also enables the late-stage functionalization of bioactive molecules. Furthermore, the reaction mechanism is thoroughly investigated through kinetic studies, Raman spectroscopy, electron paramagnetic resonance spectroscopy, and density functional theory calculations, revealing that the aminations likely involve direct homolytic cleavage of N?H bonds and subsequently controllable 1,5 or 1,6 hydrogen atom transfer.

Method for preparing amino alcohol compound by using halogenated intermediate

-

, (2020/08/22)

The invention discloses a method for preparing an amino alcohol compound by utilizing a halogenated intermediate. According to the method, an oxygen-halogen bond can be prepared by utilizing cyclic diacyl peroxide and halogenated salt under an illumination condition, and the oxygen-halogen bond is prone to homolysis under an illumination condition to form an active free radical, so the amino alcohol is finally prepared. The novel method for synthesizing the amino alcohol is high in atom utilization rate, simple in synthesis method and high in yield, so the consumption of halide for reactions with synthesis values is reduced, and the purposes of environmental protection and green chemistry are better achieved.

Enantioselective radical C–H amination for the synthesis of β-amino alcohols

Nakafuku, Kohki M.,Zhang, Zuxiao,Wappes, Ethan A.,Stateman, Leah M.,Chen, Andrew D.,Nagib, David A.

, p. 697 - 704 (2020/07/02)

Asymmetric, radical C–H functionalizations are rare but powerful tools for solving modern synthetic challenges. Specifically, the enantio- and regioselective C–H amination of alcohols to access medicinally valuable chiral β-amino alcohols remains elusive. To solve this challenge, a radical relay chaperone strategy was designed, wherein an alcohol was transiently converted to an imidate radical that underwent intramolecular H-atom transfer (HAT). This regioselective HAT was also rendered enantioselective by harnessing energy transfer catalysis to mediate selective radical generation and interception by a chiral copper catalyst. The successful development of this multi-catalytic, asymmetric, radical C–H amination enabled broad access to chiral β-amino alcohols from a variety of alcohols containing alkyl, allyl, benzyl and propargyl C–H bonds. Mechanistic experiments revealed that triplet energy sensitization of a Cu-bound radical precursor facilitates catalyst-mediated HAT stereoselectivity, enabling the synthesis of several important classes of chiral β-amines by enantioselective, radical C–H amination. [Figure not available: see fulltext.]

General Method for the Asymmetric Synthesis of N-H Sulfoximines via C-S Bond Formation

Argent, Stephen P.,Lewis, William,Mendon?a Matos, Priscilla,Moore, Jonathan c.,Stockman, Robert A.

supporting information, (2020/03/30)

A versatile method for the synthesis of enantioenriched N-H sulfoximines is reported. The approach stems from the organomagnesium-mediated ring opening of novel cyclic sulfonimidate templates. The reactions proceed in high yield and with excellent stereofidelity with alkyl, aryl, and heteroaryl Grignard reagents. The chiral auxiliary is readily removed from the resultant sulfoximines via an unusual oxidative debenzylation protocol that utilizes molecular oxygen as the terminal oxidant. This provides a general strategy for the synthesis of highly enantioenriched N-H sulfoximines.

Monofluoroalkene-Isostere as a 19F NMR Label for the Peptide Backbone: Synthesis and Evaluation in Membrane-Bound PGLa and (KIGAKI)3

Drouin, Myriam,Wadhwani, Parvesh,Grage, Stephan L.,Bürck, Jochen,Reichert, Johannes,Tremblay, Sébastien,Mayer, Marie Sabine,Diel, Christian,Staub, Alexander,Paquin, Jean-Fran?ois,Ulrich, Anne S.

supporting information, p. 1511 - 1517 (2020/02/05)

Solid-state 19F NMR is a powerful method to study the interactions of biologically active peptides with membranes. So far, in labelled peptides, the 19F-reporter group has always been installed on the side chain of an amino acid. Given the fact that monofluoroalkenes are non-hydrolyzable peptide bond mimics, we have synthesized a monofluoroalkene-based dipeptide isostere, Val-Ψ[(Z)-CF=CH]-Gly, and inserted it in the sequence of two well-studied antimicrobial peptides: PGLa and (KIGAKI)3 are representatives of an α-helix and a β-sheet. The conformations and biological activities of these labeled peptides were studied to assess the suitability of monofluoroalkenes for 19F NMR structure analysis.

Aryl olefin azole derivative as well as preparation method and application thereof

-

Paragraph 0065; 0068-0069, (2021/01/15)

The invention belongs to the technical field of medicines, and relates to an aryl olefin azole derivative shown in a general formula I, stereoisomers thereof and pharmaceutically acceptable salts, hydrates, solvates or prodrugs thereof, and substituent groups Ar, R and X have definitions given in the specification. The invention also relates to a method for preparing the compound as shown in the general formula I, a medicinal composition containing the compound and application of the compound and the medicinal composition in preparation of medicines for treating and preventing superficial fungal and deep fungal diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 56613-80-0